{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:40:13Z","timestamp":1788309613882,"version":"build-2803163510"},"reference-count":30,"publisher":"Danish Medical Association","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ugeskr L\u00e6ger"],"abstract":"<jats:p>Esophageal cancer is often diagnosed at an advanced stage, and many patients are only eligible for palliative treatment. Dysphagia secondary to local tumor extension is a frequent and debilitating symptom in these patients, often requiring intervention to increase quality of life. Management includes radiotherapy and endoscopic modalities such as stenting and argon plasma coagulation. Treatment choice should be individualised and based on patient condition and preferences, tumor location and characteristics, prognosis and prior therapy. This review finds that the optimal palliative approach remains debated.<\/jats:p>","DOI":"10.61409\/v10250832","type":"journal-article","created":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T06:41:57Z","timestamp":1782974517000},"page":"1-8","source":"Crossref","is-referenced-by-count":1,"title":["Palliative treatment of dysphagia in esophageal cancer"],"prefix":"10.61409","author":[{"given":"Amalie","family":"Dooleweerdt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merethe","family":"Br\u00e4uner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"40208","published-online":{"date-parts":[[2026,6,29]]},"reference":[{"key":"ref0","unstructured":"Dansk Esophagogastrisk Cancer Gruppe. \u00c5rsberetning for 2024, 2025. https:\/\/www.dmcg.dk\/siteassets\/arsberetninger-og-udgivelser\/arsberetninger\/2024\/degc-arsberetning-2024.pdf (07. aug 2025)"},{"key":"ref1","unstructured":"Javle M, Ailawadhi S, Yang GY et al. Palliation of malignant dysphagia in esophageal cancer: a literature-based review. J Support Oncol. 2006;4(8):365-73, 379"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"Egeland C, Bazancir LA, Bui NH et al. Palliation of dysphagia in patients with non-curable esophageal cancer - a retrospective Danish study from a highly specialized center. Support Care Cancer. 2022;30(11):9029-9038. https:\/\/doi.org\/10.1007\/s00520-022-07316-8","DOI":"10.1007\/s00520-022-07316-8"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"Dai Y, Li C, Xie Y et al. Interventions for dysphagia in oesophageal cancer. Cochrane Database Syst Rev. 2014;2014(10):CD005048. https:\/\/doi.org\/10.1002\/14651858.CD005048.pub4","DOI":"10.1002\/14651858.CD005048.pub4"},{"key":"ref4","unstructured":"Bjerring OS, Pless T, Fristrup C, Mortensen MB. Acceptable results after self-expanding metallic stent treatment for dysphagia in non-resectable oesophageal cancer. Dan Med J. 2012;59(6):A4459. https:\/\/ugeskriftet.dk\/dmj\/acceptable-results-after-self-expanding-metallic-stent-treatment-dysphagia-non-resectable"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"Eroglu A, Turkyilmaz A, Subasi M, Karaoglanoglu N. The use of self-expandable metallic stents for palliative treatment of inoperable esophageal cancer. Dis Esophagus. 2010;23(1):64-70. https:\/\/doi.org\/10.1111\/j.1442-2050.2009.00978.x","DOI":"10.1111\/j.1442-2050.2009.00978.x"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"Jim\u00e9nez-Guti\u00e9rrez JM, Alonso-L\u00e1rraga JO, Hern\u00e1ndez-Guerrero AI et al. Efficacy and safety of self-expanding metal stents in patients with inoperable esophageal cancer: a real-life study. Ther Adv Gastrointest Endosc. 2023;16:26317745231200975. https:\/\/doi.org\/10.1177\/26317745231200975","DOI":"10.1177\/26317745231200975"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"Lecleire S, Di Fiore F, Antonietti M et al. Undernutrition is predictive of early mortality after palliative self-expanding metal stent insertion in patients with inoperable or recurrent esophageal cancer. Gastrointest Endosc. 2006;64(4):479-84. https:\/\/doi.org\/10.1016\/j.gie.2006.03.930","DOI":"10.1016\/j.gie.2006.03.930"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"Kundalia R, Kodali RK, Deka D et al. Self-expandable metal stent for palliation of dysphagia in cancer esophagus at a tertiary care center of North-East India: a prospective study. Int J Surg Oncol. 2024;2024:3331040. https:\/\/doi.org\/10.1155\/ijso\/3331040","DOI":"10.1155\/ijso\/3331040"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"Norton BC, Papaefthymiou A, Aslam N et al. The endoscopic management of oesophageal strictures. Best Pract Res Clin Gastroenterol. 2024;69:101899. https:\/\/doi.org\/10.1016\/j.bpg.2024.101899","DOI":"10.1016\/j.bpg.2024.101899"},{"key":"ref10","unstructured":"DECG. Kirurgisk og endoskopisk palliation af esophaguscancer, 2025. https:\/\/www.dmcg.dk\/siteassets\/kliniske-retningslinjer\/opdelt-paa-dmcg\/esopagus--cardia--og-ventrikelcancer\/degc_kir_end_pal_esoeph_v.1.3_admgodk_190525.pdf (29. aug 2025)"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"W\u0142odarczyk JR, Ku\u017cd\u017ca\u0142 J. Stenting in palliation of unresectable esophageal cancer. World J Surg. 2018;42(12):3988-3996. https:\/\/doi.org\/10.1007\/s00268-018-4722-7","DOI":"10.1007\/s00268-018-4722-7"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"Lee JH, Yoon JY, Park SJ et al. The learning curve for colorectal stent insertion for the treatment of malignant colorectal obstruction. Gut Liver. 2012;6(3):328-33. https:\/\/doi.org\/10.5009\/GNL.2012.6.3.328","DOI":"10.5009\/gnl.2012.6.3.328"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"Spaander MCW, van der Bogt RD, Baron TH et al. Esophageal stenting for benign and malignant disease: European Society of Gastrointestinal Endoscopy (ESGE) guideline - update 2021. Endoscopy. 2021;53(7):751-762. https:\/\/doi.org\/10.1055\/a-1475-0063","DOI":"10.1055\/a-1475-0063"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"Van der Bogt RD, Vermeulen BD, Reijm AN et al. Palliation of dysphagia. Best Pract Res Clin Gastroenterol. 2018;36-37:97-103. https:\/\/doi.org\/10.1016\/j.bpg.2018.11.010","DOI":"10.1016\/j.bpg.2018.11.010"},{"key":"ref15","unstructured":"Kofoed SC, Lundsgaard M, Ellemann AC, Svendsen LB. Low morbidity after palliation of obstructing gastro-oesophageal adenocarcinoma to restore swallowing function. Dan Med J. 2012;59(6):A4434. https:\/\/ugeskriftet.dk\/dmj\/low-morbidity-after-palliation-obstructing-gastro-oesophageal-adenocarcinoma-restore-swallowing"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"Sigounas DE, Krystallis C, Couper G et al. Argon plasma coagulation compared with stent placement in the palliative treatment of inoperable oesophageal cancer. United European Gastroenterol J. 2017;5(1):21-31. https:\/\/doi.org\/10.1177\/2050640616650786","DOI":"10.1177\/2050640616650786"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"Gopakumar H, Khan H, Sharma N, Puli SR. Endoscopic spray cryotherapy for dysphagia palliation in esophageal cancer: systematic review and meta-analysis. Endosc Int Open. 2024;12(2):E211-E217. https:\/\/doi.org\/10.1055\/a-2231-7328","DOI":"10.1055\/a-2231-7328"},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"Litle VR, Luketich JD, Christie NA et al. Photodynamic therapy as palliation for esophageal cancer: experience in 215 patients. Ann Thorac Surg. 2003;76(5):1687-92. https:\/\/doi.org\/10.1016\/S0003-4975(03)01299-2","DOI":"10.1016\/S0003-4975(03)01299-2"},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"Yoon HY, Cheon YK, Choi HJ, Shim CS. Role of photodynamic therapy in the palliation of obstructing esophageal cancer. Korean J Intern Med. 2012;27(3):278-84. https:\/\/doi.org\/10.3904\/kjim.2012.27.3.278","DOI":"10.3904\/kjim.2012.27.3.278"},{"key":"ref20","unstructured":"DECG. Onkologisk behandling af ikke-kurabel cancer i esophagus og ventrikel, 2025. https:\/\/www.dmcg.dk\/siteassets\/kliniske-retningslinjer\/opdelt-paa-dmcg\/esopagus--cardia--og-ventrikelcancer\/degc_onk_palliativ_v3.0_admgodk_090425.pdf (25. maj 2025)"},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"Ajani JA, D'Amico TA, Bentrem DJ et al. Esophageal and esophagogastric junction cancers, version 2.2023. J Natl Compr Canc Netw. 2023;21(4):393-422. https:\/\/doi.org\/10.6004\/jnccn.2023.0019","DOI":"10.6004\/jnccn.2023.0019"},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"Homs MYV, Eijkenboom WMH, Coen VLMA et al. High dose rate brachytherapy for the palliation of malignant dysphagia. Radiother Oncol. 2003;66(3):327-32. https:\/\/doi.org\/10.1016\/S0167-8140(02)00410-3","DOI":"10.1016\/S0167-8140(02)00410-3"},{"key":"ref23","doi-asserted-by":"publisher","unstructured":"Lettmaier S, Strnad V. Intraluminal brachytherapy in oesophageal cancer: defining its role and introducing the technique. J Contemp Brachytherapy. 2014;6(2):236-41. https:\/\/doi.org\/10.5114\/jcb.2014.43780","DOI":"10.5114\/jcb.2014.43780"},{"key":"ref24","doi-asserted-by":"publisher","unstructured":"Homs MYV, Steyerberg EW, Eijkenboom WMH et al. Single-dose brachytherapy versus metal stent placement for the palliation of dysphagia from oesophageal cancer: multicentre randomised trial. Lancet. 2004;364(9444):1497-504. https:\/\/doi.org\/10.1016\/S0140-6736(04)17272-3","DOI":"10.1016\/S0140-6736(04)17272-3"},{"key":"ref25","doi-asserted-by":"publisher","unstructured":"Sakanaka K, Fujii K, Kokubo M et al. Improvement in quality of life and dysphagia after palliative external beam radiotherapy for malignant esophageal stenosis of esophageal cancer. JCO Oncol Pract. 2025;21(9):1306-1315. https:\/\/doi.org\/10.1200\/OP.24.00429","DOI":"10.1200\/OP.24.00429"},{"key":"ref26","doi-asserted-by":"publisher","unstructured":"Xu Z, Liu H, Li S et al. Palliative radiotherapy combined with stent insertion to relieve dysphagia in advanced esophageal carcinoma patients: a systematic review and meta-analysis. Front Oncol. 2022;12:986828. https:\/\/doi.org\/10.3389\/fonc.2022.986828","DOI":"10.3389\/fonc.2022.986828"},{"key":"ref27","doi-asserted-by":"publisher","unstructured":"Penniment MG, De Ieso PB, Harvey JA et al. Palliative chemoradiotherapy versus radiotherapy alone for dysphagia in advanced oesophageal cancer: a multicentre randomised controlled trial (TROG 03.01). Lancet Gastroenterol Hepatol. 2018;3(2):114-124. https:\/\/doi.org\/10.1016\/S2468-1253(17)30363-1","DOI":"10.1016\/S2468-1253(17)30363-1"},{"key":"ref28","doi-asserted-by":"publisher","unstructured":"Noronha V, Patil VM, Menon N et al. Phase III randomized trial comparing palliative systemic therapy to best supportive care in advanced esophageal\/GEJ cancer. Int J Cancer. 2024;155(12):2232-2245. https:\/\/doi.org\/10.1002\/ijc.35111","DOI":"10.1002\/ijc.35111"},{"key":"ref29","doi-asserted-by":"publisher","unstructured":"Touchefeu Y, Archambeaud I, Landi B et al. Chemotherapy versus self-expanding metal stent as primary treatment of severe dysphagia from unresectable oesophageal or gastro-oesophageal junction cancer. Dig Liver Dis. 2014;46(3):283-6. https:\/\/doi.org\/10.1016\/j.dld.2013.10.012","DOI":"10.1016\/j.dld.2013.10.012"}],"container-title":["Ugeskrift for L\u00e6ger"],"original-title":[],"deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T08:55:57Z","timestamp":1786697757000},"score":1,"resource":{"primary":{"URL":"https:\/\/ugeskriftet.dk\/videnskab\/V10250832"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,29]]},"references-count":30,"URL":"https:\/\/doi.org\/10.61409\/v10250832","relation":{},"ISSN":["0041-5782","1603-6824"],"issn-type":[{"value":"0041-5782","type":"print"},{"value":"1603-6824","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,29]]}}}